Michael Buchert
Michael Buchert
Olivia Newton-John Cancer Research Institute
Verified email at onjcri.org.au
Cited by
Cited by
Transcription factor AP-2 essential for cranial closure and craniofacial development
H Schorle, P Meier, M Buchert, R Jaenisch, PJ Mitchell
Nature 381 (6579), 235-238, 1996
STAT3 and STAT1 mediate IL-11–dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice
M Ernst, M Najdovska, D Grail, T Lundgren-May, M Buchert, H Tye, ...
The Journal of clinical investigation 118 (5), 1727-1738, 2008
The junction-associated protein AF-6 interacts and clusters with specific Eph receptor tyrosine kinases at specialized sites of cell–cell contact in the brain
M Buchert, S Schneider, V Meskenaite, MT Adams, E Canaani, T Baechi, ...
The Journal of cell biology 144 (2), 361-371, 1999
Ryk-deficient mice exhibit craniofacial defects associated with perturbed Eph receptor crosstalk
MM Halford, J Armes, M Buchert, V Meskenaite, D Grail, ML Hibbs, ...
Nature genetics 25 (4), 414-418, 2000
Targeting JAK kinase in solid tumors: emerging opportunities and challenges
M Buchert, CJ Burns, M Ernst
Oncogene 35 (8), 939-951, 2016
Defective claudin-7 regulation by Tcf-4 and Sox-9 disrupts the polarity and increases the tumorigenicity of colorectal cancer cells
C Darido, M Buchert, J Pannequin, P Bastide, H Zalzali, T Mantamadiotis, ...
Cancer research 68 (11), 4258-4268, 2008
Mutagenesis and selection of PDZ domains that bind new protein targets
S Schneider, M Buchert, O Georgiev, B Catimel, M Halford, SA Stacker, ...
Nature biotechnology 17 (2), 170-175, 1999
mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice
S Thiem, TP Pierce, M Palmieri, TL Putoczki, M Buchert, A Preaudet, ...
The Journal of clinical investigation 123 (2), 2013
The JAK/STAT3 axis: A comprehensive drug target for solid malignancies
J Huynh, N Etemadi, F Hollande, M Ernst, M Buchert
Seminars in cancer biology 45, 13-22, 2017
An in vitro assay of β-galactosidase from yeast
S Schneider, M Buchert, CM Hovens
Biotechniques 20 (6), 960-962, 1996
Genetic Dissection of Differential Signaling Threshold Requirements for the Wnt/β-Catenin Pathway In Vivo
M Buchert, D Athineos, HE Abud, ZD Burke, MC Faux, MS Samuel, ...
PLoS genetics 6 (1), e1000816, 2010
DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma
S Boireau, M Buchert, MS Samuel, J Pannequin, JL Ryan, A Choquet, ...
Carcinogenesis 28 (2), 246-258, 2007
Functional interaction between the ZO-1-interacting transcription factor ZONAB/DbpA and the RNA processing factor symplekin
E Kavanagh, M Buchert, A Tsapara, A Choquet, MS Balda, F Hollande, ...
Journal of cell science 119 (24), 5098-5105, 2006
Symplekin promotes tumorigenicity by up-regulating claudin-2 expression
M Buchert, M Papin, C Bonnans, C Darido, WS Raye, V Garambois, ...
Proceedings of the National Academy of Sciences 107 (6), 2628-2633, 2010
Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt–β-catenin–mediated intestinal tumor growth and regeneration
TJ Phesse, M Buchert, E Stuart, DJ Flanagan, M Faux, S Afshar-Sterle, ...
Science signaling 7 (345), ra92-ra92, 2014
Distinct requirements for the Sprouty domain for functional activity of Spred proteins
JAJ King, AFL Straffon, GM D'ABACO, CLC Poon, STT I, CM Smith, ...
Biochemical Journal 388 (2), 445-454, 2005
IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization
MF Eissmann, C Dijkstra, A Jarnicki, T Phesse, J Brunnberg, AR Poh, ...
Nature communications 10 (1), 1-16, 2019
β-Catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors
J Pannequin, N Delaunay, M Buchert, F Surrel, JF Bourgaux, J Ryan, ...
Gastroenterology 133 (5), 1554-1568, 2007
The symplekin/ZONAB complex inhibits intestinal cell differentiation by the repression of AML1/Runx1
M Buchert, C Darido, E Lagerqvist, A Sedello, C Cazevieille, F Buchholz, ...
Gastroenterology 137 (1), 156-164. e3, 2009
Elevated Dnmt3a activity promotes polyposis in ApcMin mice by relaxing extracellular restraints on Wnt signaling
MS Samuel, H Suzuki, M Buchert, TL Putoczki, NC Tebbutt, ...
Gastroenterology 137 (3), 902-913. e11, 2009
The system can't perform the operation now. Try again later.
Articles 1–20